These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study. Buyukavci R, Akturk S, Ersoy Y. Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486 [Abstract] [Full Text] [Related]
4. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial. Nam HS, Park YG, Paik NJ, Oh BM, Chun MH, Yang HE, Kim DH, Yi Y, Seo HG, Kim KD, Chang MC, Ryu JH, Lee SU. J Neurol Sci; 2015 Oct 15; 357(1-2):192-7. PubMed ID: 26233808 [Abstract] [Full Text] [Related]
7. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia. Mayer NH, Whyte J, Wannstedt G, Ellis CA. Arch Phys Med Rehabil; 2008 May 15; 89(5):982-7. PubMed ID: 18452749 [Abstract] [Full Text] [Related]
8. Time course analysis of the effects of botulinum toxin type a on elbow spasticity based on biomechanic and electromyographic parameters. Lee HM, Chen JJ, Wu YN, Wang YL, Huang SC, Piotrkiewicz M. Arch Phys Med Rehabil; 2008 Apr 15; 89(4):692-9. PubMed ID: 18374000 [Abstract] [Full Text] [Related]
9. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS investigators. Health Technol Assess; 2010 May 15; 14(26):1-113, iii-iv. PubMed ID: 20515600 [Abstract] [Full Text] [Related]
10. Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection. Hurvitz EA, Conti GE, Brown SH. Arch Phys Med Rehabil; 2003 Mar 15; 84(3):444-54. PubMed ID: 12638115 [Abstract] [Full Text] [Related]
11. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. Santamato A, Micello MF, Panza F, Fortunato F, Baricich A, Cisari C, Pilotto A, Logroscino G, Fiore P, Ranieri M. J Neurol Sci; 2014 Dec 15; 347(1-2):39-43. PubMed ID: 25263601 [Abstract] [Full Text] [Related]
14. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial. Do KH, Chun MH, Paik NJ, Park YG, Lee SU, Kim MW, Kim DK. Clin Rehabil; 2017 Sep 15; 31(9):1179-1188. PubMed ID: 28118733 [Abstract] [Full Text] [Related]
19. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study. Santamato A, Micello MF, Panza F, Fortunato F, Pilotto A, Giustini A, Testa A, Fiore P, Ranieri M, Spidalieri R. Eur J Phys Rehabil Med; 2013 Aug 15; 49(4):483-9. PubMed ID: 23480980 [Abstract] [Full Text] [Related]